3rd lesson - AiDEX CGM application
Module Content
- AiDEX app main screen
- Understand trends and arrows
- AiDEX CGM system alerts
- Enables application notifications
- Add the app in the list of allowed apps for Do Not Disturb mode.
Note:
Watch the video first, then read the sections below.
Can AiDEX reduce Hypoglycaemia (low blood glucose) unawareness?
Feeling shaky, sweating, having fast heartbeats, being nervous, being sleepy, or lacking energy are common hypoglycemic symptoms. Hyperglycemia usually occurs when blood sugar levels drop below 70 mg/dL. Despite how unpleasant hypoglycemic symptoms may be, they are very useful. These symptoms tell you that your blood sugar is low and you need to take action to bring it back into a safe range1-3.
Additionally, people suffering from hypoglycemia unawareness are unconscious that their blood sugar has dropped below a certain level and need others' assistance. Especially, when it occurs at night, it is the riskiest incident and people are less likely to be awakened from sleep 1,2,4.
Additionally, people suffering from hypoglycemia unawareness are unconscious that their blood sugar has dropped below a certain level and need others' assistance. Especially, when it occurs at night, it is the riskiest incident and people are less likely to be awakened from sleep 1,2,4.
Definitions:
Severe hypoglycaemia: Severe hypoglycaemic occurs when the person with diabetes requires external assistance and can develop quickly into seizures and coma. Prompt treatment with glucagon or intravenous dextrose or glucose is required4
References:
(1)Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.The Lancet. 2018;391(10128):1367-137
(2)Charleer S, Mathieu C, Nobels F, et al. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study.The Journal of Clinical Endocrinology & Metabolism. 2018;103(3):1224-1232.
(3) Ly TT,Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes.Diabetes Care. 2011;34(1):50-52.
(4)Williams R, Colagiuri S, Chan J, et al.IDF diabetes atlas. 9th ed. IDF diabetes atlas. International Diabetes Federation; 2019:176.
